Intrasense (ALINS) - Total Liabilities

Latest as of December 2025: €14.45 Million EUR ≈ $16.89 Million USD

Based on the latest financial reports, Intrasense (ALINS) has total liabilities worth €14.45 Million EUR (≈ $16.89 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore ALINS net asset momentum to track the company's year-over-year net asset growth rate.

Intrasense - Total Liabilities Trend (2008–2025)

This chart illustrates how Intrasense's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Intrasense to measure how efficiently the company converts operating cash flow to free cash.

Intrasense Competitors by Total Liabilities

The table below lists competitors of Intrasense ranked by their total liabilities.

Company Country Total Liabilities
RENEWABLE VENTURES NORDIC
F:X72
Germany €197.73K
Asia Seed Co.Ltd
KQ:154030
Korea ₩16.44 Billion
Mont Royal Resources Ltd
AU:MRZ
Australia AU$382.34K
Trivarx Ltd
AU:TRI
Australia AU$771.99K
Herkules S.A.
WAR:HRS
Poland zł152.01 Million
MedX Health Corp
V:MDX
Canada CA$11.28 Million
Jasper Therapeutics Inc
NASDAQ:JSPR
USA $17.78 Million
DB (International) Stock Brokers Limited
NSE:DBSTOCKBRO
India Rs402.88 Million

Liability Composition Analysis (2008–2025)

This chart breaks down Intrasense's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Intrasense stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.26 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -2.24 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.81 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Intrasense's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Intrasense (2008–2025)

The table below shows the annual total liabilities of Intrasense from 2008 to 2025.

Year Total Liabilities Change
2025-12-31 €14.45 Million
≈ $16.89 Million
+139.65%
2024-12-31 €6.03 Million
≈ $7.05 Million
+90.52%
2023-12-31 €3.17 Million
≈ $3.70 Million
-29.62%
2022-12-31 €4.50 Million
≈ $5.26 Million
+18.87%
2021-12-31 €3.78 Million
≈ $4.42 Million
-10.10%
2020-12-31 €4.21 Million
≈ $4.92 Million
+15.83%
2019-12-31 €3.63 Million
≈ $4.25 Million
+62.78%
2018-12-31 €2.23 Million
≈ $2.61 Million
-3.94%
2017-12-31 €2.32 Million
≈ $2.72 Million
-23.55%
2016-12-31 €3.04 Million
≈ $3.55 Million
-22.58%
2015-12-31 €3.93 Million
≈ $4.59 Million
+5.42%
2014-12-31 €3.72 Million
≈ $4.35 Million
-9.28%
2013-12-31 €4.11 Million
≈ $4.80 Million
+1.47%
2012-12-31 €4.05 Million
≈ $4.73 Million
-33.73%
2011-12-31 €6.11 Million
≈ $7.14 Million
+85.71%
2010-12-31 €3.29 Million
≈ $3.84 Million
+210.42%
2009-12-31 €1.06 Million
≈ $1.24 Million
+22.00%
2008-12-31 €868.00K
≈ $1.01 Million
--

About Intrasense

PA:ALINS France Health Information Services
Market Cap
$13.79 Million
€11.80 Million EUR
Market Cap Rank
#26328 Global
#442 in France
Share Price
€0.22
Change (1 day)
-0.88%
52-Week Range
€0.19 - €0.31
All Time High
€2.17
About

Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that… Read more